NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis

被引:23
作者
Licata, Anna [1 ]
Corrao, Salvatore [2 ]
Petta, Salvatore [1 ]
Genco, Chiara [1 ]
Cardillo, Mauro [2 ]
Calvaruso, Vincenza [1 ]
Cabibbo, Giuseppe [1 ]
Massenti, Fatima [3 ]
Camma, Calogero [1 ]
Licata, Giuseppe [2 ]
Craxi, Antonio [1 ]
机构
[1] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy
[2] Univ Palermo, Sez Med Interna & Cardioangiol, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy
[3] Univ Palermo, Dipartimento Sci Promoz Salute, Sez Igiene, Palermo, Italy
来源
PLOS ONE | 2013年 / 8卷 / 08期
关键词
BRAIN NATRIURETIC PEPTIDE; CARDIOMYOPATHY; DYSFUNCTION; RATS;
D O I
10.1371/journal.pone.0068364
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Aims: Plasma levels of NT-pro-BNP, a natriuretic peptide precursor, are raised in the presence of fluid retention of cardiac origin and can be used as markers of cardiac dysfunction. Recent studies showed high levels of NT pro BNP in patients with cirrhosis. We assessed NT pro-BNP and other parameters of cardiac dysfunction in patients with cirrhosis, with or without ascites, in order to determine whether the behaviour of NT pro BNP is linked to the stage of liver disease or to secondary cardiac dysfunction. Methods: Fifty eight consecutive hospitalized patients mostly with viral or NAFLD-related cirrhosis were studied. All underwent abdominal ultrasound and upper GI endoscopy. Cardiac morpho-functional changes were evaluated by echocardiography and NT-pro-BNP plasma levels determined upon admission. Twenty-eight hypertensive patients, without evidence of liver disease served as controls. Results: Fifty eight cirrhotic patients (72% men) with a median age of 62 years (11% with mild arterial hypertension and 31% with type 2 diabetes) had a normal renal function (mean creatinine 0.9 mg/dl, range 0.7-1.06). As compared to controls, cirrhotic patients had higher NT pro-BNP plasma levels (365.2 +/- 365.2 vs 70.8 +/- 70.6 pg/ml; p<0.001). Left atrial volume (LAV) (61.8 +/- 26.3 vs 43.5 +/- 14.1 ml; p = 0.001), and left ventricular ejection fraction (62.7 +/- 6.9 vs. 65.5 +/- 4%,; p = 0.05) were also altered in cirrhotic patients that in controls. Patients with F2-F3 oesophageal varices as compared to F0/F1, showed higher e' velocity (0.91 +/- 0.23 vs 0.66 +/- 0.19 m/s, p<0.001), and accordingly a higher E/A ratio (1.21 +/- 0.46 vs 0.89 +/- 0.33 m/s., p = 0.006). Conclusion: NT-pro-BNP plasma levels are increased proportionally to the stage of chronic liver disease. Advanced cirrhosis and high NT-pro-BNP levels are significantly associated to increased LAV and to signs of cardiac diastolic dysfunction. NT pro-BNP levels could hence be an useful prognostic indicators of early decompensation of cirrhosis.
引用
收藏
页数:7
相关论文
共 28 条
  • [21] BNP as marker of heart dysfunction in patients with liver cirrhosis
    Padillo, Javier
    Rioja, Pilar
    Munoz-Villanueva, Maria C.
    Vallejo, Juan A.
    Ciria, Ruben
    Muntane, Jordi
    Sitges-Serra, Antonio
    Solorzano, Guillermo
    De la Mata, Manuel
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (11) : 1331 - 1336
  • [22] B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis
    Pimenta, Joana
    Paulo, Cristiana
    Gomes, Andre
    Silva, Sergio
    Rocha-Goncalves, Francisco
    Bettencourt, Paulo
    [J]. LIVER INTERNATIONAL, 2010, 30 (07) : 1059 - 1066
  • [23] Pozzi M, 1997, HEPATOLOGY, V26, P1131
  • [24] The Relationship between the Transforming Growth Factor beta 1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects
    Scaglione, Rosario
    Argano, Christiano
    Duro, Giovanni
    Di Chiara, Tiziana
    Nuzzo, Domenico
    Colomba, Daniela
    Fiore, Maria Cristina
    Corrao, Salvatore
    Licata, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF HYPERTENSION, 2010, 2010
  • [25] Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine
    Weber, M
    Hamm, C
    [J]. HEART, 2006, 92 (06) : 843 - 849
  • [26] Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
    Wong, F
    Siu, S
    Liu, P
    Blendis, LM
    [J]. CLINICAL SCIENCE, 2001, 101 (06) : 621 - 628
  • [27] Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients
    Yildiz, R
    Yildirim, B
    Karincaoglu, M
    Harputluoglu, M
    Hilmioglu, F
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (07) : 1115 - 1120
  • [28] Cirrhotic Cardiomyopathy
    Zardi, Enrico M.
    Abbate, Antonio
    Zardi, Domenico Maria
    Dobrina, Aldo
    Margiotta, Domenico
    Van Tassel, Benjamin W.
    Afeltra, Antonella
    Sanyal, Arun J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (07) : 539 - 549